620 related articles for article (PubMed ID: 32238649)
1. Smart Strategies for Therapeutic Agent Delivery into Brain across the Blood-Brain Barrier Using Receptor-Mediated Transcytosis.
Tashima T
Chem Pharm Bull (Tokyo); 2020; 68(4):316-325. PubMed ID: 32238649
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human.
Zhang W; Liu QY; Haqqani AS; Leclerc S; Liu Z; Fauteux F; Baumann E; Delaney CE; Ly D; Star AT; Brunette E; Sodja C; Hewitt M; Sandhu JK; Stanimirovic DB
Fluids Barriers CNS; 2020 Jul; 17(1):47. PubMed ID: 32698806
[TBL] [Abstract][Full Text] [Related]
3. Brain Cancer Chemotherapy through a Delivery System across the Blood-Brain Barrier into the Brain Based on Receptor-Mediated Transcytosis Using Monoclonal Antibody Conjugates.
Tashima T
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884906
[TBL] [Abstract][Full Text] [Related]
4. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
Stanimirovic DB; Sandhu JK; Costain WJ
BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
[TBL] [Abstract][Full Text] [Related]
5. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
Choi ES; Shusta EV
Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
[TBL] [Abstract][Full Text] [Related]
6. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges.
Choi H; Choi K; Kim DH; Oh BK; Yim H; Jo S; Choi C
Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336049
[TBL] [Abstract][Full Text] [Related]
7. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
8. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
[TBL] [Abstract][Full Text] [Related]
9. Approaches to CNS Drug Delivery with a Focus on Transporter-Mediated Transcytosis.
Abdul Razzak R; Florence GJ; Gunn-Moore FJ
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242683
[TBL] [Abstract][Full Text] [Related]
10. Transcellular brain drug delivery: A review on recent advancements.
Azarmi M; Maleki H; Nikkam N; Malekinejad H
Int J Pharm; 2020 Aug; 586():119582. PubMed ID: 32599130
[TBL] [Abstract][Full Text] [Related]
11. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated therapeutic transport across the blood-brain barrier.
Wang YY; Lui PC; Li JY
Immunotherapy; 2009 Nov; 1(6):983-93. PubMed ID: 20635914
[TBL] [Abstract][Full Text] [Related]
13. Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer's, and Tumor Mouse Models.
Israel LL; Galstyan A; Cox A; Shatalova ES; Sun T; Rashid MH; Grodzinski Z; Chiechi A; Fuchs DT; Patil R; Koronyo-Hamaoui M; Black KL; Ljubimova JY; Holler E
ACS Nano; 2022 Aug; 16(8):11815-11832. PubMed ID: 35961653
[TBL] [Abstract][Full Text] [Related]
14. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core.
Clark AJ; Davis ME
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563
[TBL] [Abstract][Full Text] [Related]
15. Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin.
Tashima T
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171799
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
17. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive approaches for drug delivery to the brain based on the receptor mediated transport.
Fang F; Zou D; Wang W; Yin Y; Yin T; Hao S; Wang B; Wang G; Wang Y
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1316-1327. PubMed ID: 28482500
[TBL] [Abstract][Full Text] [Related]
19. Integrin α
Huang CW; Chuang CP; Chen YJ; Wang HY; Lin JJ; Huang CY; Wei KC; Huang FT
J Nanobiotechnology; 2021 Jun; 19(1):180. PubMed ID: 34120610
[TBL] [Abstract][Full Text] [Related]
20. Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges.
Parrasia S; Szabò I; Zoratti M; Biasutto L
Mol Pharm; 2022 Nov; 19(11):3700-3729. PubMed ID: 36174227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
